ePurines, Inc is a drug development company based in Salt Lake City, UT, specializing in innovative purinergic-based therapies for obesity, metabolic syndrome, renal, and liver diseases. Their core technologies, developed in the VA labs and licensed from the US Department of Veterans Affairs, form the foundation of their value proposition, which aims to target diseases affecting both US Veterans and the general population.
ePurines leverages their expertise in purinergic signaling and their proprietary technology platform to develop novel drug treatments, with a focus on addressing the healthcare needs of veterans and the wider community. With a strong emphasis on research and development, ePurines is committed to advancing the field of purinergic-based therapies to improve the lives of individuals affected by these diseases.
Generated from the website